Kwality Pharmaceuticals Limited (NSE:KPL)

Kwality Pharmaceuticals Revenue

Kwality Pharmaceuticals had revenue of 1.62B INR in the quarter ending June 30, 2026, with 45.63% growth. This brings the company's total for the last twelve months to 5.54B, up 37.94% year-over-year. In the fiscal year ending March 31, 2026, Kwality Pharmaceuticals had annual revenue of 5.03B with 35.90% growth.

• Revenue (ttm): 5.54B
• Revenue Growth: +37.94%
• P/S Ratio: 7.22
• Revenue / Employee: 4.87M
• Employees: 1,137
• Market Cap: 40.02B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 2.53B 50.3%
• Export 2.50B 49.7%
• Mozambique 244.00K 0.0%

Fiscal year ended Mar 31, 2026 See the full Kwality Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	5.03B	1.33B	35.90%
Mar 31, 2025	3.70B	630.25M	20.52%
Mar 31, 2024	3.07B	561.42M	22.36%
Mar 31, 2023	2.51B	-2.05B	-44.97%
Mar 31, 2022	4.56B	1.93B	73.42%

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error